Topic: Health
A study found that postmenopausal women who took hormone therapy and a medication called tirzepatide lost about 35% more weight than those taking only the medication. This could help treat obesity and related health issues.
This study, led by Mayo Clinic, looked at how menopausal hormone therapy affects weight loss in postmenopausal women. The researchers found that women who took both hormone therapy and tirzepatide lost significantly more weight than those taking only tirzepatide. On average, they lost about 35% more weight.
Menopause is often associated with increased weight gain and a higher risk of developing obesity-related health problems, such as cardiovascular disease and type 2 diabetes. Declining estrogen levels during menopause can also trigger other changes in the body that may increase cardiovascular risk.
Hormone therapy remains the most effective first-line option for relieving common menopausal symptoms like hot flashes and night sweats, which affect up to 75% of postmenopausal women. However, its potential role in enhancing weight-loss medications has not been well understood.
The study's findings suggest that hormone therapy may play a role in enhancing the effects of GLP-1-based medications like tirzepatide. This could lead to new possibilities for treating obesity and related health conditions in postmenopausal women.
Why It Matters
This research matters because it could help develop more effective strategies for managing cardiometabolic risk in postmenopausal women, which is a significant concern in India where menopause-related health issues are on the rise.
Key Facts
- Postmenopausal women who took both hormone therapy and tirzepatide lost about 35% more weight than those taking only tirzepatide.
- Menopause is often associated with increased weight gain and a higher risk of developing obesity-related health problems.
- Hormone therapy remains the most effective first-line option for relieving common menopausal symptoms like hot flashes and night sweats.
- The study's findings suggest that hormone therapy may play a role in enhancing the effects of GLP-1-based medications like tirzepatide.
Key Terms
- Menopause
- A natural biological process in women where estrogen levels decline, leading to physical and emotional changes.
Implications
This research matters because it could help develop more effective strategies for managing cardiometabolic risk in postmenopausal women, which is a significant concern in India where menopause-related health issues are on the rise.
Source: https://www.sciencedaily.com/releases/2026/03/260323005543.htm
Journal Reference:
- Regina Castaneda, Dima Bechenati, Elif Tama, Rene Rivera Gutierrez, Maria A Espinosa, Jose Villamarin, Tamim I Rajjo, Andres Acosta, Stephanie Faubion, Chrisandra Shufelt, Maria D Hurtado Andrade. The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study. The Lancet Obstetrics, Gynaecology,, 2026; 2 (2): e118 DOI: 10.1016/S3050-5038(25)00145-1
Leave a Comment